We transform the fight against cancer

Christine Davis is the President of Ontada, an oncology real world data and technology business dedicated to improving the lives of cancer patients through its life science and provider solutions.

Ms. Davis has more than 25 years of experience in life science consulting, predominately in Oncology. Prior to joining Ontada, Christine was the Global Head of Commercial Research & Consulting at Cerner Enviza (part of Oracle Life Sciences) across 10 countries in North America, Europe, and Asia. In this position she lead Oracle's Data Products in Oncology and Specialty, as well as its Research, Analytics, and Consulting businesses.

Ms. Davis has held various other leadership positions during her tenure at Cerner (formally Kantar Health), including General Manager of Oncology & Specialty, General Manager of Marketing Insights, Chief Operating Officer, and Head of Business Insights (quantitative analytics), first in the U.S., then globally.

Chris Frey is the assistant general counsel, where she leads the legal team supporting Ontada’s customers, strategies and solutions.

Previously, Chris was assistant general counsel for McKesson’s Prescription Technology Solutions. She also has experience in private practice at a large law firm focused on technology solutions, mergers & acquisitions and public-private partnerships.

Chris holds a J.D. from the University of Michigan, where she graduated cum laude.

“When Ontada succeeds, oncology patients and their care communities will experience unprecedented positive outcomes due to cutting-edge and affordable care driven by the power of data insights.”

John Hopkins is the vice president of compliance & ethics for Ontada where he oversees operational compliance, ethics and privacy programs while helping balance the strategic business needs with regulatory and legal requirements.

John joined McKesson in 2013 and has held numerous roles in policy governance, data privacy and compliance leadership in other McKesson technology service lines including Macro Helix and CoverMyMeds.

Prior to McKesson, John worked for WebMD.com for more than 16 years where he helped define, build and oversee WebMD’s compliance & ethics programs for technology services and websites serving consumers, physicians and health plans. He started his life-long career in healthcare as a respiratory therapist in the U.S. Army. His last clinical role as a civilian was at the National Institutes of Health (NIH) in Bethesda, Maryland.

John holds a Bachelor of Science degree in Communications from Kennesaw State University. 

Matt Johnson is the senior vice president and chief financial officer for Ontada. In this role, he leads the finance team for the growing business and his responsibilities include financial reporting and controls, financial planning and analysis, and managing investments in product growth, including mergers & acquisitions (M&A), identifying risk and managing the working capital investment.

Matt has been at McKesson for 12 years and has served in roles of increasing responsibility throughout his tenure. Most recently, Matt was the senior vice president of corporate financial planning and analysis and M&A finance. Matt has also held finance director roles in both McKesson Europe and McKesson’s Pharmaceutical and Specialty Solutions businesses.

Matt holds a Bachelor of Science in biochemistry from the University of Tennessee and an M.B.A. from Vanderbilt’s Owen School of Management.

Sagran Moodley is the Chief Innovation and Technology Officer for Ontada. In this role, he is responsible for Ontada’s data infrastructure, integrity, insights, and security as well as the development of the core technologies and systems that power Ontada’s diverse software suites.

Sagran has more than 25 years of experience leading transformative healthcare IT and business initiatives. Most recently, Sagran served as Senior Vice President of Clinical Data Services and Technology for UnitedHealthcare Clinical Services, responsible for the clinical technology strategies for over 55 million members across UnitedHealthcare’s Medicare, Medicaid, and Commercial lines of business.

Sagran has a passion for advancing industry-wide interoperability data exchange standards. He has an active leadership role in several data standardization initiatives. He was the co-founder and current chair of the Da Vinci Project, a private-public sector initiative focusing on clinical data exchange standards (interoperability) between payers and providers supporting value-based care delivery. He also serves on the Health Level Seven (HL7) Advisory Council and is a member of the Executive Steering Committee of the Gravity Project, focusing on standardizing the approach to collecting social determinants of health (SDOH) information from provider organizations.

He holds a B.S. in Computer Science from the University of South Africa and completed graduate study coursework at Harvard Business School in healthcare administration and healthcare delivery.

Viraj Narayanan is the chief commercial officer at Ontada. In this position, he is responsible for commercial operations, from go-to-market strategy through commercial execution.

Prior to joining Ontada, Viraj served as the General Manager and Senior Vice President of the Life Sciences Business at COTA, an oncology real-world data and analytics company. He led the scaling of COTA’s life sciences business, bridging the gap between stakeholder needs, including the go-to-market strategy for the business unit. Before COTA, he held leadership positions at Heidrick & Struggles and Decision Strategies International, providing strategic consulting services to providers and life science companies. Viraj’s previous experiences also include research at Centocor, a Johnson & Johnson company, and the University of Pennsylvania’s Natural Language Processing Department.

Viraj holds a Bachelor of Science in Decision Science from Carnegie Mellon University and a Master of Business Administration from the Wharton School at the University of Pennsylvania.

Tina Page is the vice president of human resources for Ontada. In this role, she leads the human resources team and serves as an executive advisor to senior leadership. She is responsible for talent strategy, organization design, change management and culture, with a focus on inclusion and diversity.

Tina has been with McKesson for 6-years and has served in multiple roles of increasing responsibility, most recently as the vice president of HR for The US Oncology Network. Previous to McKesson, Tina served in senior leadership roles with considerable expertise leading and shaping high-performance cultures for start-ups and top Fortune 500 corporations in diverse industries including REIT’s (real estate investment trusts), distribution operations with Amazon and in medical devices with Stryker. Her extensive and unique experience in executive leadership, business operations and innovation/process improvement have continuously driven impactful and value-driven results and legacies. Additionally, she serves as the executive sponsor of the employee resource group, PAVE (Pan-Asian Voices of Excellence), which focuses its efforts on providing professional development, fostering business excellence by harnessing strengths found in diverse backgrounds, building cultural awareness and engaging in community events.

Tina holds a Bachelor of Arts degree in Communications with a minor in Business Management from the University of New Orleans.

Nicholas J. Robert is the chief medical officer at Ontada. In this position, he is responsible for deepening Ontada’s clinical focus and expertise. He also collaborates across the organization to ensure studies, real-world data offerings and educational programs maintain the highest scientific standards and clinical relevance.

Nick previously held the role of VP, Medical Affairs at Ontada where he oversaw the development and completion of real-world evidence studies, including the MYLUNG Consortium™ Protocol 1. Nick has spent much of his career as a practicing oncologist, including as Medical Director of the research program at Virginia Cancer Specialists and Clinical Director of Medical Oncology at Tufts Medical Center.

A leader in community oncology, Nick has authored more than 100 publications and serves as a reviewer for medical journals, including the Journal of Clinical Oncology-Clinical Cancer Informatics. He is a member of several industry organizations, including the American Society of Clinical Oncology (ASCO), and is board certified in Internal Medicine, Anatomic Pathology, Medical Oncology, and Hematology.

Nick received his medical degree from McGill Medical School and completed residencies at Royal Victoria Hospital and Massachusetts General Hospital and fellowships at the Brigham and Women’s Hospital and Dana Farber Cancer Institute. He was a Fellow at Harvard Medical School.